Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FL2B3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $94,645
Award facts
- Contract value 100% obligated
- $94,645.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $94,645.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nucala 100 mg/ml auto-injectors. The contract, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. This delivery order carries no set-aside designation, and the contractor will fulfill the order at its Park Ridge facility.
DMS Pharmaceutical Group is an established federal pharmaceutical supplier that has maintained significant contract relationships with the Defense Logistics Agency since its SAM.gov registration in 2001. The company operates under a substantial $499.99 million single-award IDC with the DLA's SPE2DB program, which remains valid through November 2026 and authorizes the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. This particular delivery order for Nucala auto-injectors aligns with the contractor's core business of distributing prescription medications, biologics, and specialty pharmaceutical products to Department of Defense healthcare sites across the nation.
Quick answers
Who was awarded contract SPE2DB25FL2B3?
SPE2DB25FL2B3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FL2B3 worth?
The government has obligated $94,645 on SPE2DB25FL2B3.
Is contract SPE2DB25FL2B3 an order under another contract?
Yes. SPE2DB25FL2B3 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL2B3 competed?
The extent of competition for SPE2DB25FL2B3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award